Financial Reports Latest Updates Industry Maps Economic Calendar

MIMEDX GROUP, INC. (MDXG) Annual Reports

Q: Where can I read MIMEDX GROUP, INC. (MDXG) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

MIMEDX GROUP, INC. is listed on Nasdaq, classified by the SEC under Surgical & Medical Instruments & Apparatus (SIC 3841). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1376339 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$64.4M	$98.6M	-34.7%
Operating income	$-18.5M	$12.4M	-249.3%
Net income	$-14.8M	$9.6M	-254.3%
EPS (diluted)	$-0.10	$0.06	-266.7%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 64.4 mn Net income -14.8 mn

Show table：Income statement

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	0.32	0.11	0.24	1.04	1.93	2.15	2.64	3.71	4.88	7.95	10.5	11.6	13.5	16.1	18.0	19.6	25.6	33.5	39.6	40.8	45.7	49.0	51.8	53.4	57.3	64.4	69.9	68.8	80.5	84.0	87.9	84.2	95.4	87.0	92.6	66.6	67.4	88.9	76.4	61.7	53.6	64.3	68.5	60.0	68.2	63.1	67.4	58.9	66.9	67.7	74.4	71.7	81.3	81.7	86.8	84.7	87.2	84.1	92.9	88.2	98.6	114	118	59.0	64.4
Gross profit	—	—	—	0.33	1.08	1.27	1.72	2.75	3.77	6.53	8.82	9.65	11.3	14.0	14.9	16.6	22.8	30.2	36.0	35.6	40.6	44.0	46.9	45.4	50.0	56.4	60.8	63.9	67.8	75.0	78.5	74.8	86.2	79.6	82.2	59.1	57.7	75.7	63.7	51.7	45.5	54.0	57.7	50.3	55.4	53.0	56.7	49.0	55.1	55.5	60.0	59.3	67.7	66.9	73.0	71.7	72.3	68.7	76.0	71.7	79.9	95.0	99.0	41.6	44.4
Operating income	-2.70	-2.85	-2.43	-3.26	-2.42	-1.65	-2.44	-0.63	-0.12	-3.63	-0.97	-0.23	-0.74	-0.26	-1.41	-0.89	-0.39	3.73	4.65	4.25	5.65	6.71	7.75	1.47	3.56	4.70	8.72	6.19	7.21	8.84	24.0	2.97	1.68	0.37	-8.94	-13.4	-17.1	14.2	-4.87	-13.7	-5.86	-9.71	-16.1	-6.85	-0.41	-1.07	3.30	-9.30	-9.64	-7.10	1.07	-3.38	2.79	10.8	26.9	13.2	23.4	11.2	11.1	8.25	12.4	22.2	21.1	-16.1	-18.5
Net income	-2.70	-2.85	-2.73	-3.35	-2.50	-1.77	-2.58	-1.09	-0.74	-4.22	-1.61	-1.62	-0.76	-0.31	-1.43	-0.92	-0.39	3.70	3.83	4.09	5.43	6.55	13.4	1.20	1.98	3.32	5.48	4.33	8.07	17.5	4.28	4.62	1.80	-0.18	-36.2	-13.3	-17.2	12.4	-7.48	-4.82	-8.47	-19.4	-16.6	-8.38	-1.78	-2.34	2.22	-10.5	-10.9	-8.43	-0.41	-4.98	1.20	8.53	53.5	9.26	17.6	8.10	7.44	7.02	9.62	16.8	15.2	-10.9	-14.8

Balance sheet

Quarterly · In mn (USD)

Total assets 281 mn Total liabilities 65.0 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	1.71	—	3.62	3.00	6.88	7.05	7.86	16.1	18.1	20.7	21.5	25.9	65.4	67.9	66.3	77.3	85.7	82.3	91.8	103	96.3	95.2	102	106	127	122	133	114	48.8	—	—	—	74.0	57.2	123	134	123	116	108	171	161	150	148	142	149	136	131	136	134	132	141	155	164	139	154	172	192	200	221	254	277	240	205
Total assets	—	—	7.35	—	24.3	23.6	27.1	26.9	27.5	33.5	35.2	37.9	40.3	45.3	84.7	87.3	86.0	97.3	109	106	114	126	136	177	177	182	193	188	200	179	121	—	—	—	123	107	170	179	167	159	151	213	202	191	187	181	188	174	169	173	171	168	176	189	239	222	230	244	264	270	291	319	343	309	281
Current liabilities	—	—	1.25	—	5.56	6.83	7.92	6.80	8.24	10.6	5.07	5.97	6.14	8.33	9.61	9.59	9.91	14.4	18.4	18.5	19.5	24.4	26.8	28.8	38.5	41.6	50.7	49.6	51.5	35.2	45.8	—	—	—	71.5	64.3	78.1	73.4	67.3	63.7	63.7	57.3	59.2	55.4	50.6	41.8	42.4	36.6	37.1	45.9	43.6	40.9	44.5	43.6	46.0	42.2	40.0	41.9	45.6	42.6	50.3	57.7	64.3	44.5	38.5
Total liabilities	—	—	1.25	—	11.4	11.7	15.2	14.4	11.8	14.3	15.2	6.26	7.39	9.76	11.1	11.1	11.5	16.1	19.9	19.7	20.6	25.4	27.9	63.0	55.5	58.4	60.3	59.5	52.6	36.2	47.5	—	—	—	73.2	69.1	146	140	133	129	128	109	111	107	102	93.8	95.3	89.4	89.8	99.8	96.9	93.6	96.5	95.2	96.3	66.0	62.1	62.9	70.8	67.6	74.5	80.0	86.1	65.7	65.0
Equity	—	—	6.10	—	12.9	11.8	11.9	12.5	15.7	19.2	20.0	31.6	32.9	35.5	73.6	76.2	74.5	81.3	89.3	86.4	93.2	101	108	114	122	123	133	129	147	142	73.8	75.3	81.2	84.7	49.7	38.4	24.7	39.6	34.4	30.3	22.9	12.9	-0.15	-8.05	-7.14	-5.81	0.08	-7.43	-13.6	-19.5	-18.0	-17.9	-12.7	1.33	143	156	168	181	193	203	217	239	257	243	216

Cash flow

Quarterly · In mn (USD)

Operating -10.0 mn Investing -0.63 mn Financing -13.3 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-3.90	-2.27	-1.99	-1.79	-2.13	-1.09	-1.66	-1.29	-0.31	-0.86	-0.92	-2.10	-0.76	1.73	0.84	-1.61	1.18	8.95	8.28	4.21	2.93	7.31	4.36	-0.98	7.28	2.85	16.7	10.6	13.5	17.9	20.9	10.2	20.7	3.40	1.53	-15.3	2.13	-3.16	-23.1	-12.3	-3.10	-4.62	-10.3	-6.68	1.60	6.33	-3.23	-10.2	-3.00	0.96	-5.62	-4.05	7.78	12.8	10.3	5.98	21.8	19.6	18.8	5.30	14.4	29.3	25.0	1.88	-10.0
Investing	-0.12	-0.03	0	-0.43	-0.18	-0.27	0.18	-0.05	-0.19	-0.16	-0.18	-0.07	-1.32	-1.14	-0.49	-0.63	-0.8	-0.87	-9.84	-1.05	-0.12	-1.10	1.59	-9.29	0.57	-1.73	-1.29	-0.97	-1.78	-1.39	-1.25	-3.11	-2.47	-2.45	-1.19	-0.43	-0.33	2.06	-0.79	-1.09	-0.49	-0.71	-2.27	-2.08	-0.42	-0.58	-0.31	-0.15	-0.43	-0.37	-1.71	-0.68	-0.35	-0.65	-0.48	-6.02	-0.9	0.11	-2.77	-0.41	-0.89	-5.26	-0.33	-5.64	-0.63
Financing	4.10	0	2.90	1.90	2.90	0.39	4.95	0.24	0.14	5.99	0.24	1.14	0.55	1.28	37.7	1.19	-4.15	-0.07	0.89	-11.1	-2.91	-3.73	-18.5	-3.11	0.83	-6.58	0.67	-13.1	4.91	-27.6	-24.6	-8.09	-0.33	-0.22	-0.28	-1.04	66.8	-1.71	-1.14	-2.18	-1.75	66.7	-1.24	-2.31	-0.92	-0.15	0.02	-1.04	0.26	0.13	0.07	0	0	0.37	-8.94	-33.5	-0.36	0.03	-0.4	-2.88	-1.09	-0.86	-0.58	-2.58	-13.3
Cash at period end	2.73	0.43	1.34	1.02	1.61	0.64	4.11	3.02	2.65	7.62	6.75	5.73	4.19	6.06	44.1	43.0	39.3	47.3	46.6	38.7	38.6	41.1	28.5	15.1	23.8	18.3	34.4	30.9	47.5	36.5	27.5	26.4	44.3	45.1	45.1	28.4	96.9	94.1	69.1	53.5	48.2	110	95.8	84.8	85.0	90.6	87.1	75.7	72.5	73.2	66.0	61.2	68.7	81.2	82.0	48.5	69.0	88.8	104	106	119	142	166	160	136

Profitability

Quarterly · %

Gross margin 69.0% Operating margin -28.7% Net margin -23.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	31.9%	56.2%	58.8%	65.2%	74.1%	77.2%	82.1%	83.9%	83.5%	83.7%	86.9%	82.7%	84.8%	89.3%	90.0%	90.9%	87.4%	88.9%	89.8%	90.4%	85.1%	87.1%	87.6%	87.0%	92.8%	84.2%	89.3%	89.3%	88.9%	90.3%	91.5%	88.8%	88.8%	85.5%	85.1%	83.4%	83.8%	84.7%	84.0%	84.2%	83.9%	81.3%	83.9%	84.0%	83.1%	82.3%	82.0%	80.7%	82.7%	83.3%	81.9%	84.1%	84.7%	83.0%	81.8%	81.8%	81.2%	81.0%	83.5%	83.9%	70.6%	69.0%
Operating margin	-837.6%	-2641.8%	-997.2%	-312.1%	-125.2%	-76.8%	-92.4%	-17.0%	-2.4%	-45.7%	-9.3%	-2.0%	-5.5%	-1.6%	-7.8%	-4.6%	-1.5%	11.1%	11.8%	10.4%	12.4%	13.7%	14.9%	2.8%	6.2%	7.3%	12.5%	9.0%	9.0%	10.5%	27.3%	3.5%	1.8%	0.4%	-9.7%	-20.1%	-25.3%	16.0%	-6.4%	-22.3%	-10.9%	-15.1%	-23.5%	-11.4%	-0.6%	-1.7%	4.9%	-15.8%	-14.4%	-10.5%	1.4%	-4.7%	3.4%	13.2%	31.0%	15.6%	26.9%	13.3%	11.9%	9.3%	12.6%	19.5%	17.9%	-27.2%	-28.7%
Net margin	-837.3%	-2642.3%	-1117.9%	-320.8%	-129.8%	-82.0%	-97.8%	-29.5%	-15.2%	-53.0%	-15.3%	-14.0%	-5.6%	-1.9%	-7.9%	-4.7%	-1.5%	11.0%	9.7%	10.0%	11.9%	13.4%	25.8%	2.2%	3.4%	5.2%	7.8%	6.3%	10.0%	20.8%	4.9%	5.5%	1.9%	-0.2%	-39.1%	-19.9%	-25.5%	13.9%	-9.8%	-7.8%	-15.8%	-30.2%	-24.2%	-14.0%	-2.6%	-3.7%	3.3%	-17.8%	-16.3%	-12.4%	-0.6%	-7.0%	1.5%	10.4%	61.6%	10.9%	20.2%	9.6%	8.0%	8.0%	9.8%	14.7%	12.9%	-18.4%	-23.1%

Returns & leverage

Quarterly · %

ROE 2.9% ROA 2.2% Debt ratio 23.1%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	-88.5%	-87.3%	-113.3%	-63.5%	-43.2%	-55.6%	-48.0%	-37.1%	-33.8%	-15.7%	-8.8%	-6.3%	-5.7%	1.6%	7.6%	13.8%	20.3%	21.9%	29.9%	26.5%	21.5%	17.8%	9.9%	12.4%	15.8%	26.6%	33.0%	33.7%	24.6%	9.3%	-48.6%	-84.3%	-126.4%	-87.4%	-60.9%	-49.9%	-35.3%	-153.2%	-287.8%	-474.2%	-587.1%	-823.6%	—	—	—	—	—	—	—	—	93.4%	105.2%	114.4%	97.0%	25.3%	22.4%	16.7%	19.4%	21.6%	13.8%	2.9%
ROA	—	—	—	—	-47.1%	-43.9%	-59.2%	-29.6%	-23.9%	-30.3%	-24.6%	-25.3%	-24.2%	-10.9%	-6.9%	-5.5%	-4.8%	1.4%	6.4%	11.6%	17.1%	17.8%	24.0%	18.8%	15.9%	12.9%	7.3%	8.3%	11.3%	19.6%	21.7%	—	—	—	-24.6%	-44.6%	-39.3%	-30.3%	-17.6%	-12.9%	-5.2%	-20.5%	-26.7%	-30.2%	-27.3%	-14.8%	-5.3%	-6.8%	-12.1%	-15.6%	-16.8%	-14.4%	-7.3%	2.4%	28.4%	37.2%	43.7%	40.9%	16.9%	16.3%	12.3%	14.5%	16.0%	10.6%	2.2%
Debt ratio	—	—	17.0%	—	46.8%	49.7%	56.1%	53.5%	43.0%	42.8%	43.1%	16.5%	18.4%	21.5%	13.1%	12.7%	13.4%	16.5%	18.2%	18.6%	18.1%	20.2%	20.6%	35.5%	31.3%	32.1%	31.2%	31.5%	26.3%	20.3%	39.1%	—	—	—	59.6%	64.3%	85.5%	77.9%	79.4%	80.9%	84.8%	51.3%	54.8%	56.0%	54.4%	52.0%	50.7%	51.2%	53.2%	57.8%	56.5%	55.7%	54.7%	50.4%	40.3%	29.8%	27.0%	25.8%	26.8%	25.0%	25.6%	25.1%	25.1%	21.3%	23.1%

EPS

Quarterly · US$

EPS US$-0.10

Show table：EPS

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	-0.01	-0.01	-0.05	-0.01	-0.02	-0.01	0.00	-0.01	-0.01	0.00	0.03	0.03	0.04	0.05	0.06	0.11	0.01	0.02	0.03	0.05	0.04	0.07	0.15	0.04	0.04	0.02	0.00	-0.34	-0.12	-0.16	0.11	-0.07	-0.04	-0.08	-0.48	-0.17	-0.09	-0.03	-0.04	0.00	-0.11	-0.11	-0.09	-0.02	-0.06	0.00	0.06	0.37	0.06	0.12	0.05	0.05	0.05	0.06	0.11	0.10	-0.07	-0.10

Revenue & profit

Year-to-date · In mn (USD)

Revenue 123 mn Net income -25.7 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 281 mn Total liabilities 65.0 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -8.14 mn Investing -6.28 mn Financing -15.9 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 69.7% Operating margin -28.0% Net margin -20.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 2.9% ROA 2.2% Debt ratio 23.1%

EPS

Year-to-date · US$

EPS US$-0.17

Revenue & profit

Annual · In mn (USD)

Revenue 419 mn Net income 48.6 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	7.76	27.1	59.2	118	187	245	321	359	299	248	259	268	321	349	419
Gross profit	4.40	21.9	49.9	106	167	213	285	323	256	209	215	220	267	289	346
Operating income	-9.76	-5.36	-2.64	7.10	24.4	18.4	46.2	-3.92	-21.2	-45.4	-5.04	-25.0	37.1	58.9	63.9
Net income	-10.2	-7.66	-4.11	6.22	29.4	12.0	34.1	-30.0	-25.6	-49.3	-10.3	-30.2	58.2	42.4	48.6

Balance sheet

Annual · In mn (USD)

Total assets 343 mn Total liabilities 86.1 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	6.88	18.1	65.4	85.7	96.3	127	48.8	74.0	123	161	149	134	164	192	277
Total assets	27.1	35.2	84.7	109	136	193	121	123	167	202	188	171	239	264	343
Current liabilities	7.92	5.07	9.61	18.4	26.8	50.7	45.8	71.5	67.3	59.2	42.4	43.6	46.0	45.6	64.3
Total liabilities	15.2	15.2	11.1	19.9	27.9	60.3	47.5	73.2	133	111	95.3	96.9	96.3	70.8	86.1
Equity	11.9	20.0	73.6	89.3	108	133	73.8	49.7	34.4	-0.15	0.08	-18.0	143	193	257

Cash flow

Annual · In mn (USD)

Operating 74.0 mn Investing -6.89 mn Financing -5.41 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-6.66	-3.38	-0.29	16.8	18.8	25.8	62.9	35.8	-39.4	-30.3	-1.98	-17.9	26.8	66.2	74.0
Investing	-0.7	-0.58	-3.03	-12.2	-0.68	-11.7	-5.40	-9.22	0.5	-4.55	-3.39	-2.66	-2.15	-9.58	-6.89
Financing	10.1	6.61	40.6	-2.15	-36.2	-8.18	-60.4	-8.93	62.9	61.6	-3.35	-0.58	-8.57	-34.2	-5.41
Cash at period end	4.11	6.75	44.1	46.6	28.5	34.4	27.5	45.1	69.1	95.8	87.1	66.0	82.0	104	166

Profitability

Annual · %

Gross margin 82.6% Operating margin 15.3% Net margin 11.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	56.7%	80.8%	84.2%	89.3%	89.2%	86.8%	88.8%	89.9%	85.6%	84.2%	83.3%	82.0%	83.0%	82.8%	82.6%
Operating margin	-125.8%	-19.8%	-4.5%	6.0%	13.0%	7.5%	14.4%	-1.1%	-7.1%	-18.3%	-1.9%	-9.3%	11.5%	16.9%	15.3%
Net margin	-131.4%	-28.3%	-7.0%	5.3%	15.7%	4.9%	10.6%	-8.3%	-8.6%	-19.9%	-4.0%	-11.3%	18.1%	12.2%	11.6%

Returns & leverage

Annual · %

ROE 21.6% ROA 16.0% Debt ratio 25.1%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-85.7%	-48.0%	-8.8%	7.6%	29.9%	9.9%	33.0%	-48.6%	-60.9%	-287.8%	—	—	93.4%	25.3%	21.6%
ROA	-37.6%	-24.6%	-6.9%	6.4%	24.0%	7.3%	21.7%	-24.6%	-17.6%	-26.7%	-5.3%	-16.8%	28.4%	16.9%	16.0%
Debt ratio	56.1%	43.1%	13.1%	18.2%	20.6%	31.2%	39.1%	59.6%	79.4%	54.8%	50.7%	56.5%	40.3%	26.8%	25.1%

EPS

Annual · US$

EPS US$0.32

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	-0.08	-0.04	0.05	0.26	0.11	0.30	-0.28	-0.24	-0.77	-0.16	-0.33	0.37	0.28	0.32

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read MIMEDX GROUP, INC. (MDXG) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.